Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Aug 29;23(6):348-350.
doi: 10.1177/15357597231197105. eCollection 2023 Nov-Dec.

Cenobamate: Real-World Experience Matches Clinical Trials

Gewalin Aungaroon  1
Affiliations
Comment

Cenobamate: Real-World Experience Matches Clinical Trials

Gewalin Aungaroon. Epilepsy Curr. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Comment on

References

    1. Chung SS, French JA, Kowalski J, et al. Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures. Neurology. 2020;94(22):e2311–e2322. doi:10.1212/WNL.0000000000009530 - PMC - PubMed
    1. Krauss GL, Klein P, Brandt C, et al. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial. Lancet Neurol. 2020;19(1):38–48. doi:10.1016/S1474-4422(19)30399-0 - PubMed
    1. Klein P, Aboumatar S, Brandt C, et al. Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures. Neurology. 2022;99(10):e989–998. doi:10.1212/WNL.0000000000200792 - PMC - PubMed
    1. Sperling MR, Abou-Khalil B, Aboumatar S, et al. Efficacy of cenobamate for uncontrolled focal seizures: post hoc analysis of a phase 3, multicenter, open-label study. Epilepsia. 2021;62(12):3005–3015. doi:10.1111/epi.17091 - PMC - PubMed
    1. Pena-Ceballos J, Moloney PB, Munteanu T, et al. Adjunctive cenobamate in highly active and ultra-refractory focal epilepsy: a “real-world” retrospective study. Epilepsia. 2023;64(5):1225–1235. doi:10.1111/epi.17549 - PubMed

LinkOut - more resources